SARS-CoV-2 vaccine (Betta Pharmaceutical)

N/A

Report date: 2025/01/26 16:18:23

Base Information

Drug NameSARS-CoV-2 vaccine (Betta Pharmaceutical)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapyVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine +[4] 
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBetta Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBetta Pharmaceuticals Co LtdBeijing DCTY Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A